Onego Bio: Transforming the Egg Protein Industry Through Precision Fermentation
July 19, 2024, 9:32 am
Onego Bio, a pioneering Finnish startup, has recently secured a substantial €14 million in funding to propel its cutting-edge precision-fermented egg protein production. This significant investment marks a pivotal moment for the company as it continues to revolutionize the way egg proteins are produced and utilized in the food industry.
At the heart of Onego Bio's innovation is its Bioalbumen protein, a sustainable and animal-free alternative to traditional egg proteins. By harnessing the power of precision fermentation, Onego Bio has developed a bio-identical egg protein that offers a stable supply, full functionality, perfect protein quality, and a neutral flavor. This breakthrough technology not only addresses the growing demand for sustainable food solutions but also has the potential to alleviate the environmental burden associated with conventional egg production by up to 90%.
The applications of Onego Bio's Bioalbumen protein are vast and varied, spanning across a wide range of food products including baked goods, confectionery, snacks, sauces, pasta, and meat alternatives. By collaborating with major food companies on product formulation, Onego Bio is actively working towards integrating its innovative protein into everyday food items, offering consumers a more sustainable and environmentally friendly choice.
In addition to its focus on commercializing Bioalbumen in North America, Onego Bio is also making strides towards securing regulatory approval and commercialization in the EU. The company's commitment to sustainability and efficiency has garnered recognition from the European Innovation Council (EIC) Accelerator Program and other Series A investors, further solidifying its position as a leader in the precision fermentation foodtech space.
As Onego Bio continues to expand its operations and scale up production, it is poised to disrupt the egg protein market and pave the way for a more sustainable and environmentally conscious food system. With its patented fungal fermentation technology and plans for a state-of-the-art manufacturing unit, Onego Bio is on track to offer competitive pricing compared to conventional egg production methods, while delivering a protein equivalent to that produced by six million laying hens.
In a world where sustainability and innovation are paramount, Onego Bio stands at the forefront of a new era in the food industry, where precision fermentation and bio-identical proteins are reshaping the way we think about food production and consumption. Through its commitment to sustainability, efficiency, and quality, Onego Bio is not just transforming the egg protein industry – it's shaping the future of food.
At the heart of Onego Bio's innovation is its Bioalbumen protein, a sustainable and animal-free alternative to traditional egg proteins. By harnessing the power of precision fermentation, Onego Bio has developed a bio-identical egg protein that offers a stable supply, full functionality, perfect protein quality, and a neutral flavor. This breakthrough technology not only addresses the growing demand for sustainable food solutions but also has the potential to alleviate the environmental burden associated with conventional egg production by up to 90%.
The applications of Onego Bio's Bioalbumen protein are vast and varied, spanning across a wide range of food products including baked goods, confectionery, snacks, sauces, pasta, and meat alternatives. By collaborating with major food companies on product formulation, Onego Bio is actively working towards integrating its innovative protein into everyday food items, offering consumers a more sustainable and environmentally friendly choice.
In addition to its focus on commercializing Bioalbumen in North America, Onego Bio is also making strides towards securing regulatory approval and commercialization in the EU. The company's commitment to sustainability and efficiency has garnered recognition from the European Innovation Council (EIC) Accelerator Program and other Series A investors, further solidifying its position as a leader in the precision fermentation foodtech space.
As Onego Bio continues to expand its operations and scale up production, it is poised to disrupt the egg protein market and pave the way for a more sustainable and environmentally conscious food system. With its patented fungal fermentation technology and plans for a state-of-the-art manufacturing unit, Onego Bio is on track to offer competitive pricing compared to conventional egg production methods, while delivering a protein equivalent to that produced by six million laying hens.
In a world where sustainability and innovation are paramount, Onego Bio stands at the forefront of a new era in the food industry, where precision fermentation and bio-identical proteins are reshaping the way we think about food production and consumption. Through its commitment to sustainability, efficiency, and quality, Onego Bio is not just transforming the egg protein industry – it's shaping the future of food.